Fidelis Capital Partners’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.33M Buy
25,628
+6,018
+31% +$549K 0.13% 123
2026
Q1
$2.01M Sell
19,610
-8,912
-31% -$1.01M 0.14% 123
2025
Q4
$3.57M Buy
28,522
+1,992
+8% +$254K 0.26% 80
2025
Q3
$3.55M Buy
26,530
+6,240
+31% +$819K 0.28% 73
2025
Q2
$2.66M Buy
20,290
+95
+0.5% +$12.5K 0.24% 74
2025
Q1
$2.6M Buy
20,195
+226
+1% +$28.8K 0.28% 73
2024
Q4
$2.57M Buy
19,969
+1,332
+7% +$154K 0.26% 74
2024
Q3
$2.18M Buy
18,637
+2,254
+14% +$247K 0.26% 77
2024
Q2
$1.8M Sell
16,383
-1,340
-8% -$142K 0.26% 76
2024
Q1
$2.01M Sell
17,723
-253
-1% -$29K 0.31% 63
2023
Q4
$1.98M Buy
17,976
+3,382
+23% +$338K 0.44% 50
2023
Q3
$1.41M Buy
14,594
+317
+2% +$33.3K 0.48% 46
2023
Q2
$1.56M Buy
14,277
+386
+3% +$41.1K 0.57% 40
2023
Q1
$1.55M Buy
13,891
+8,720
+169% +$921K 0.66% 37
2022
Q4
$580K Buy
+5,171
New +$535K 0.68% 47

Other funds holding ABT

Fidelis Capital Partners's ABT Position: Q2 2026 in Review

Fidelis Capital Partners increased its Abbott (ABT) stake by 31% in Q2 2026, buying an estimated $549K and bringing the position to 25,628 shares worth $2.33M. The position accounts for 0.13% of the portfolio, ranked #123.

Fidelis Capital Partners first reported a position in ABT in Q4 2022 and has held it in 15 quarters since. The position peaked at $3.57M in Q4 2025. 2,982 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Fidelis Capital Partners held 25,628 shares of Abbott worth $2.33M as of Q2 2026.
  • Fidelis Capital Partners bought 6,018 Abbott shares in Q2 2026, an estimated $549K.
  • Abbott made up 0.13% of Fidelis Capital Partners's portfolio in Q2 2026, its #123 holding.
  • Fidelis Capital Partners first reported a position in Abbott in Q4 2022 and has held it in 15 quarters since.
  • Fidelis Capital Partners's Abbott position peaked at $3.57M in Q4 2025.
  • 2,982 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Fidelis Capital Partners's 13F filing for Q2 2026, filed 13 Aug 2026.